Search results: Sage Journals

Open accessResearch articleFirst published January, 2021

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

Mohamed A. Yassin, Rola S. Ghasoub, Mahmood B. Aldapt [...]

Cancer Control

Available accessResearch articleFirst published December, 2025

Efficacy of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors (TKIs) in advanced hepatocellular carcinoma: a comparison with transarterial chemoembolization combined with TKIs

Lei Fan, Lei Wang

Acta Radiologica

Free accessResearch articleFirst published November, 2017

Rituximab effectively reverses Tyrosine kinase inhibitors (TKIs) resistance through inhibiting the accumulation of rictor on mitochondria-associated ER-membrane (MAM)

Zhi-Hong Xu, Cai-Hong Liu, Jun-Biao Hang [...]

Cancer Biomarkers

Open accessReview articleFirst published 2012

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Chao H. Huang, Benjamin C. Powers

Clinical Medicine Insights: Oncology

Open accessReview articleFirst published 2015

More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds

Maria Vergoulidou

Biomarker Insights

Open accessResearch articleFirst published March, 2024

Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia

James B Collins, Benyam Muluneh, Sarah Profitt

Journal of Oncology Pharmacy Practice

Available accessCase reportFirst published December, 2021

Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report

Fabio Turco, Marcello Tucci, Rosario Francesco Di Stefano [...]

Tumori Journal

Open accessResearch articleFirst published 2024

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Rawan Dawoud, Harman Saman, Kakil Rasul [...]

Clinical Medicine Insights: Oncology

Available accessResearch articleFirst published March, 2026

A Rapid Review of Supportive Care Management of Treatment-Related Acute and Long-Term Cardiac Toxicities in Children with Cancer and Childhood Cancer Survivors Who Have Received Tyrosine Kinase Inhibitors (TKIs)

Beth Fisher, Mary Keller, Nancy Dias [...]

Journal of Pediatric Hematology/Oncology Nursing

Available accessCase reportFirst published October, 2017

Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia

Tomohiko Ozaki, Hajime Nakamura, Nobuyuki Izutsu [...]

Interventional Neuroradiology

Open accessResearch articleFirst published January, 2021

Effects of Intermittent Fasting on Response to Tyrosine Kinase Inhibitors (TKIs) in Patients With Chronic Myeloid Leukemia: An Outcome of European LeukemiaNet Project

Mohamed A. Yassin, Rola S. Ghasoub, Mahmood B. Aldapt [...]

Cancer Control

Available accessResearch articleFirst published December, 2025

Efficacy of hepatic artery infusion chemotherapy combined with tyrosine kinase inhibitors (TKIs) in advanced hepatocellular carcinoma: a comparison with transarterial chemoembolization combined with TKIs

Lei Fan, Lei Wang

Acta Radiologica

Free accessResearch articleFirst published November, 2017

Rituximab effectively reverses Tyrosine kinase inhibitors (TKIs) resistance through inhibiting the accumulation of rictor on mitochondria-associated ER-membrane (MAM)

Zhi-Hong Xu, Cai-Hong Liu, Jun-Biao Hang [...]

Cancer Biomarkers

Open accessReview articleFirst published 2012

The Evolving Role of Maintenance Therapy Using Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors (EGFR TKIs) in the Management of Advanced Non-Small-Cell Lung Cancer

Chao H. Huang, Benjamin C. Powers

Clinical Medicine Insights: Oncology

Open accessReview articleFirst published 2015

More than a Decade of Tyrosine Kinase Inhibitors in the Treatment of Solid Tumors: What We Have Learned and What the Future Holds

Maria Vergoulidou

Biomarker Insights

Open accessResearch articleFirst published March, 2024

Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia

James B Collins, Benyam Muluneh, Sarah Profitt

Journal of Oncology Pharmacy Practice

Available accessCase reportFirst published December, 2021

Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report

Fabio Turco, Marcello Tucci, Rosario Francesco Di Stefano [...]

Tumori Journal

Open accessResearch articleFirst published 2024

Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non–Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study

Rawan Dawoud, Harman Saman, Kakil Rasul [...]

Clinical Medicine Insights: Oncology

Available accessResearch articleFirst published March, 2026

A Rapid Review of Supportive Care Management of Treatment-Related Acute and Long-Term Cardiac Toxicities in Children with Cancer and Childhood Cancer Survivors Who Have Received Tyrosine Kinase Inhibitors (TKIs)

Beth Fisher, Mary Keller, Nancy Dias [...]

Journal of Pediatric Hematology/Oncology Nursing

Available accessCase reportFirst published October, 2017

Intracranial stenting for nilotinib treatment-associated cerebrovascular stenosis in chronic myeloid leukemia

Tomohiko Ozaki, Hajime Nakamura, Nobuyuki Izutsu [...]

Interventional Neuroradiology